Summary Here we report that the slow-transforming helper component of Friend murine leukaemia virus (Fr-MLV) 
Summary Here we report that the slow-transforming helper component of Friend murine leukaemia virus (Fr-MLV) , which produces lymphoid leukaemias in normal mice, induces erythroleukaemia in mice given syngeneic pituitary grafts (SPG). Newborn mice were infected with Fr-MLV and, at one month of age, were transplanted with two pituitary glands under the kidney capsule. Sham-operated infected mice and uninfected transplanted mice served as controls. SPG selectively reduced the mean survival times of infected mice. Histolpathology showed that, while most infected non-transplanted mice developed lymphoid leukaemias, virtually all Fr-MLF-infected mice given SPG developed erythroleukaemias. Experiments in vitro showed that Fr-MLV infection markedly depressed concanavalin A induced DNA synthesis in cells from spleen, thymus and lymph nodes. Addition of prolactin or growth hormone further suppressed lectin-induced mitogenesis of lymphoid cells from infected mice, but failed to influence the response of uninfected controls. These experiments indicate that, in mice, pituitary hormones modulate the development and the histological features of Fr-MLV induced leukaemias, and suggest that endocrine-immunological interactions play a role in retrovirus induced tumorigenesis.
In previous studies on the interference between mammary tumour virus and Friend leukaemia viruses in mice (FLV; Basolo et al., 1985) , we noticed that adult BALB/c mice infected with the slow-transforming helper component of FLV (designed Fr-MLV) developed erythroleukaemias when given syngeneic pituitary grafts (SPG). The peculiarity of this finding is that Fr-MLV does induce lymphoid leukaemias in normal animals. Our interest in this finding was revived by recent reports on the possibility of a heightened incidence of leukaemias in growth hormone (GH) deficient children treated with pituitary and/or recombinant GH Frisch et al., 1988; Dean, 1988; Butenandt, 1988; Ogawa et al., 1988; Sasaki et al., 1988) . Although it is uncertain whether a relationship exists between hypopituitarism, GH treatment and leukaemia, it has been proposed that GH treatment might interact with environmental agents, such as viruses, to produce neoplasias (Report of the International Workshop on GH and Leukaemia, 1988) .
It is now becoming clear that functional interactions do occur between the endocrine and the immune system (for a review see Berczi & Kovacs, 1987) . For instance, lymphoid cells can produce ACTH in response to different stimuli (Blalock, 1987) , receptors for steroid hormones are present in lymphoid cells of all species (Homo-Delarche & Duval, 1987) , human lymphocytes and cell lines bear receptors for insulin and GH (Lesniak et al., 1987; Gauwerky et al., 1980) , macrophages are stimulated by GH to produce the superoxide anion (Edwards et al., 1988) .
In experimental models, the hormone dependence of lymphoid tumors has long been known: the incidence of spontaneous lymphomas is increased by oestrogens in various animals and the development of oestrogeninduced lymphomas in NB rats is suppressed by drugs interfering with the secretion of pituitary hormones . Conversely, hypopysectomy reduces the incidence of leukaemia following infection of rats with Gross virus and causes chemically induced leukaemias to regress (Benteley et al., 1974; Huggins & Oka, 1972; Huggins & Veda, 1984) . In mice, SPG have been found to favour the development of chemically-induced leukaemias (Karande & Ranadive, 1973) , and GH and prolactin (PRL) have been shown to stimulate the growth of cultured erythroleukaemia cells (Golde et al., 1978 (Rowson & Parr, 1970) . Fr-MLV was propagated in vivo in adult BALB/c mice and checked free of contamination by both SFFV (absence of marked and rapidly progressing splenomegaly in adult mice, no development of erythroleukaemia) and the lactic dehyrogenase virus (infected mice have normal LDH levels). Virus preparation consisted of filtered plasma with a titer of 3 x I05 PFU ml-' as tested on monolayers of murine FG 10 (S+L-) cells (Toniolo et al., 1984) . This strain has been extensively used in previous work and is immunosuppressive in adult as well as in newborn mice (Bendinelli et al., 1985) . In our mice, the induction of erythroleukaemia by Fr-MLV depends on the age of animals at the time of infection. Mice older than 2-3 days never develop erythroleukaemia; however, the disease occurs when mice are infected within 24 h from birth (unpublished observations Plasma levels of PRL and GH were measured in a few transplanted mice. The mean levels of PRL were significantly higher in SPG recipients than in sham-operated mice (35.7 ± 7.2 vs 6.6 ± 1.8, respectively; mean ± s.e.m., n = 5 in both groups), while GH levels were approximately the same in both groups (26.4 ± 8.2 vs 23.3 + 5.2; mean ± s.e.m.). These results are in good agreement with published data which indicate that PRL is the main product of ectopically transplanted pituitaries (Labrie et al., 1978; Fernandez-Ruiz et al., 1987) .
Histopathology At the time of death (i.e. 100-270 days after transplant), SPG take was assessed in each animal by histologic examination of the right kidney. By morphological criteria, transplanted pituitaries were clearly viable in all infected mice. The histopathology of Fr-MLV induced neoplasias was markedly different in the two groups of animals. In shamoperated infected mice, the neoplastic process was essentially confined to the spleen and lymph nodes; histopathological changes were not found in the thymus. According to the criteria of Chesebro et al. (1983) showed that 6/17 animals had lymphoid leukaemia, 8/17 had mixed lymphoid and myeloid leukaemia, 2/17 had myeloid leukaemia, and one had mixed lymphoid-erythroid leukaemia. The neoplastic involvement of the spleen was predominantly periarteriolar and the lymphatic follicles were replaced by leukaemic cells which were adjacent to the fibrous trabeculae and infiltrated the red pulp (Figure 2a ). In contrast, 18 out of 20 infected mice given SPG showed erythroid leukaemias characterised by hyperbasophilic small round cells infiltrating the red pulp of the spleen and liver sinusoids, as well as by large atypical cells with clear cytoplasms and vesciculated nuclei (Figure 2 b-d) ; over 10% of spleen cells were positive for a-naphthyl butyrate esterase (Figure 2 e) Ruscetti et al., 1981; . showed that a single dominant locus (designed Fv6) controls erythroleukemia induction by this virus in newborn mice. Fv6 appears to have no influence on adult mice and personal observations) and is distinct from the other loci (Fv2 and Fv5) which are specific for SFFV and regulate the proliferation of erythroid precursors. Fv6 is specific for Fr-MLV and probably acts on haemopoietic tissue differentiation . Whatever its mode of action, BALB/c mice (which are Fv6-) are considered permissive to the induction of erythroleukaemia when infected within 1 day of birth, whereas in our experiments BALB/c mice infected at 7 to 10 days of age failed to develop erytholeukaemia if not given pituitary grafts.
This apparent discrepancy may derive from the peculiar experimental design adopted in this study. Purposely, we injected mice older than 1 day of age with extremely low doses of virus in order to delay tumour development and leave enough time for endocrine mechanisms to play their (Labrie et al., 1978; Bercz & Nagy, 1987) , it seems that, in this system, PRL favoured directly the virus induced transformation and proliferation of erythroid precursors. Pregnancy, which is associated with increased levels of PRL, is also characterised by enhanced erythropoiesis, and it is known that PRL and GH control haemolymphopoietic cells through the c-myc gene (Berczi & Nagy, 1987; Gout et al., 1980) . Thus, Fr-MLV transformed erythroid precursors might express PRL receptors responsible for their pituitary dependency, as in the case of the Nb2 rat lymphoma which is dependent on PRL for growth in vivo . This hypothesis awaits confirmation.
An alternative explanation would be that high levels of pituitary hormones could favour indirectly the growth of virally induced tumours by suppressing the immune response to the tumour itself. With regard to normal hosts, this hypothesis seems untenable since PRL and GH have been shown to potentiate-not to depress-immune functions (Berczi & Nagy, 1987) . Even in our experiments in vitro, both PRL and GH failed to depress the proliferative response of uninfected lymphoid cells. However, the activation of Fr-MLV infected lymphoid cells was markedly inhibited by both hormones. This observation suggests that also in vivo PRL and GH could worsen viral induced immunodeficiency and favour tumour progression. Although this may appear not significant in view of the profound immunosuppression produced by Fr-MLV some months after infection, the hormone mediated immunosuppression might favour the spread of virus and of virus transformed cells in the early phase of infection, when only mild immunosuppression is found (Bendinelli et al., 1985) .
In conclusion, recent clinical observations together with new experimental approaches begin to clarify the interplay between transforming viruses, the immune and the endocrine systems. Our model system, which closely mimics the human situation due to the long latency of the viral process, indicates that pituitary hormones may act directly by stimulating the growth of transformed cells, and indirectly by lowering the host's immune defences.
